Experimental Lilly drug neutralises Omicron in lab; slightly higher risk of diabetes seen in kids after COVID Read more
Caris Life Sciences and HotSpot Therapeutics collaborate to advance precision medicine development for difficult-to-drug therapeutic targets Read more
Novartis and Molecular Partners report positive topline data from phase-II study for Ensovibep Read more